SC
MRNA icon

Syon Capital’s Moderna MRNA Stock Holding History

Syon Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Buy
5,681
+472
+9% +$24.4K 0.02% 715
2026
Q1 		$265K Buy
+5,209
New +$243K 0.01% 781
2025
Q3 		– Sell
-9,918
Closed -$274K – 836
2025
Q2 		$274K Buy
+9,918
New +$261K 0.02% 580
2025
Q1 		– Sell
-11,134
Closed -$463K – 633
2024
Q4 		$463K Buy
+11,134
New +$532K 0.04% 302
2024
Q3 		– Sell
-2,595
Closed -$308K – 480
2024
Q2 		$308K Buy
2,595
+709
+38% +$89.7K 0.03% 345
2024
Q1 		$201K Buy
+1,886
New +$190K 0.02% 430

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Syon Capital's MRNA Position: Q2 2026 in Review

Syon Capital increased its Moderna (MRNA) stake by 9.1% in Q2 2026, buying an estimated $24.4K and bringing the position to 5,681 shares worth $398K. The position accounts for 0.02% of the portfolio, ranked #715.

Syon Capital first reported a position in MRNA in Q1 2024 and has held it in 6 quarters since. The position peaked at $463K in Q4 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Syon Capital held 5,681 shares of Moderna worth $398K as of Q2 2026.
  • Syon Capital bought 472 Moderna shares in Q2 2026, an estimated $24.4K.
  • Moderna made up 0.02% of Syon Capital's portfolio in Q2 2026, its #715 holding.
  • Syon Capital first reported a position in Moderna in Q1 2024 and has held it in 6 quarters since.
  • Syon Capital's Moderna position peaked at $463K in Q4 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.